济南什么办法改善早泄济南之前列腺需多少费用,济南治早泄最快的药,济南前列腺炎能否治疗好,济南治疗男性阳痿的药,济南男生射精快怎么治疗,济南得了早射怎么调理好,济南哪家医院看男科好

BEIJING, July 11 (Xinhuanet) -- U.S. federal government officially announced that it denied the medical use of marijuana."Department of Health and Human Services concluded that marijuana has a high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision," U.S. Department of Justice declared Friday.The announcement will keep marijuana in the classification of dangerous, addictive drug as heroin.The decision comes almost nine years after medical marijuana advocates asked the government to reclassify marijuana, as its therapeutic effectiveness in treating some diseases and relieving pain of patients.Joe Elford, the chief counsel for Americans for Safe Access (ASA), said he was not surprised by the government's disapproval."It is clearly motivated by a political decision that is anti-marijuana," He noted.This is the third petition to reclassify marijuana has failed to be approved. The former two were filed in 1972 and in 1995, respectively.

BEIJING, Sept. 26 (Xinhuanet) -- Weather forecasts showed that Thursday or Friday might be suitable for launching the Tiangong-1 spacecraft, experts said.The unmanned spacecraft, part of China's first spacecraft rendezvous and docking mission, was set to blast off from the Jiuquan Satellite Launch Center in Northwest China at an appropriate time between Tuesday and Friday.But the latest weather forecast showed that Tuesday and Wednesday would not be suitable for a launch, Cui Jijun, chief commander of the mission's launch site system, was quoted by China National Radio as saying on Sunday.A precondition for launching is that the average wind speed at the launch site should not be faster than 10 meters a second. The upper-level wind, at 300 meters to 25,000 meters above the Earth, should be no faster than 70 meters a second.The 8.5-ton Tiangong-1 spacecraft and the Long March II-F rocket stand at the Jiuquan Satellite Launch Center on Sept 20. The spacecraft is set to blast off at an appropriate time between Tuesday and Friday.If the wind is too strong, the rising rocket carrier could wiggle and pose a danger, experts said."Everything is ready now except for the right weather," Cui said.On Sunday afternoon, all systems of the Tiangong-1 project went through a joint maneuver, he said. Before that, the 8.5-ton spacecraft, and the Long March II-F rocket that will carry it skyward, were positioned onto the launch pad last Tuesday.Engineers carried out checkups on the conditions of the rocket and the spacecraft, among many other tests in the past few days. All preparation work is done except for fuel loading, he said.Wang Xiaoqing, a publicity official at the launch site, said that the fuel loading usually begins one day before the launch. Once the fuel is loaded into the carrier vehicle, the launch becomes "irreversible".Tiangong-1, or Heavenly Palace 1, will serve as "a target spacecraft" for three rendezvous and docking experiments.The spacecraft rendezvous and docking missions are expected to pave the way for the building of a planned space station scheduled for 2020, previous reports said.Following Tiangong-1, an unmanned Shenzhou VIII spaceship will blast off from the Jiuquan Satellite Launch Center later this year.Lu Jinrong, chief engineer of the mission's launch site system, said that it is rare that two launches of China's manned space program are scheduled in half a year."In the past, the launch site carried out one launch a year, or even one every two to three years," he said."We are already in a high-frequency launch period."

BEIJING, Aug. 12 (Xinhuanet) -- The risk of developing coronary heart disease is 25 percent higher for women smokers compared with men, according to a study published in the British medical journal "The Lancet".The authors say this could be due to the physiological differences between the sexes with cigarette smoke toxins having a more potent effect on women.The study by Dr Rachel R Huxley from the University of Minnesota and Dr Mark Woodward from Johns Hopkins University involved a meta-analysis of around four million individuals and 67,000 coronary heart disease events from 86 studies.The researchers found that the pooled adjusted female-to-male relative risk ratio (RRR) of smoking compared with not smoking for coronary heart disease (CHD) was 1.25 (25 percent) higher for women.This RRR increased by 2 percent for every additional year of follow-up, meaning that the longer a woman smokes, the higher her risk of developing CHD becomes compared with a man who has smoked the same length of time.The authors say, "The finding lends support to the idea of a pathophysiological basis for the sex difference. For example, women might extract a greater quantity of carcinogens and other toxic agents from the same number of cigarettes than men. This occurrence could explain why women who smoke have double the risk of lung cancer compared with their male counterparts."Worldwide, there are 1.1 billion smokers, of whom a fifth are women.According to the Tobacco Atlas, India, with around a crore female smokers, ranks third in the top 20 female smoking populations across the globe, only the U.S. with 2.3 crore female smokers and China with 1.3 crore female smokers, are worse off.

New York, Sept. 23 (Xinhua) -- A Chinese scientist was presented a prestigious U.S. award on Friday for the discovery of artemisinin, a drug therapy for malaria that has saved millions of lives across the globe, especially in the developing world. Pharmacologist Tu Youyou, 81, became the first scientist on the Chinese mainland to win Lasker Award, known as "America's Nobels" for their knack of gaining future recognition by the Nobel committee.Tu, a scientist at the China Academy of Chinese Medical Sciences in Beijing, pioneered a new approach to malaria treatment that has benefited hundreds of millions of people and promises to benefit many times more. By applying modern techniques and rigor to a heritage provided by 5000 years of Chinese traditional practitioners, she has delivered its riches into the 21st century."Not often in the history of clinical medicine can we celebrate a discovery that has eased the pain and distress of hundreds of millions of people and saved the lives of countless numbers of people, particularly children, in over 100 countries," Lucy Shapiro, a member of the award jury and professor of Stanford University, said while describing Tu' s discovery.Shapiro said the discovery, chemical identification, and validation of artemisinin, a highly effective anti-malarial drug, is largely due to the "scientific insight, vision and dogged determination" of Professor Tu and her team. She thought Professor Tu's work has provided the world with arguably the most important pharmaceutical intervention in the last half century."The discovery of artemisinin is a gift to mankind from traditional Chinese medicine," Tu said while receiving the award. "Continuous exploration and development of traditional medicine will, without doubt, bring more medicines to the world."